Analysis of 1144 lung cancer tumors comprising lung adenocarcinomas and lung squamous cell carcinomas revealed FGF10 amplifications in 8.7% and FGFR1 amplifications in 9.3% of cases (Campbell J. D. et al., 2016). Here, FGF10 is linked to lung cancer.